Preliminary clinical results of our therapeutic cancer vaccine in patients with stage IV NSCLC accepted for an oral presentation at the prestigious annual meeting of the AACR
We are delighted to announce that our abstract on the preliminary clinical results of the therapeutic cancer vaccine PDC*lung01 in patients (pts) with stage IV NSCLC was accepted for an oral presentation at the prestigious annual meeting of the